[go: up one dir, main page]

EA201792445A1 - Новые амидогетероарилароилгидразидэтины - Google Patents

Новые амидогетероарилароилгидразидэтины

Info

Publication number
EA201792445A1
EA201792445A1 EA201792445A EA201792445A EA201792445A1 EA 201792445 A1 EA201792445 A1 EA 201792445A1 EA 201792445 A EA201792445 A EA 201792445A EA 201792445 A EA201792445 A EA 201792445A EA 201792445 A1 EA201792445 A1 EA 201792445A1
Authority
EA
Eurasian Patent Office
Prior art keywords
new
hydrazidethines
amidogeteroariloroilyl
preparation
tyrosine kinase
Prior art date
Application number
EA201792445A
Other languages
English (en)
Other versions
EA032697B1 (ru
Inventor
Хемант Ашвинбхаи Чокши
Саббирхусен Юсуфбхаи Чиманвала
Варун Анилкумар Мехта
Прабал Сенгупта
Читтури Тринадха Рао
Original Assignee
Сан Фарма Адвансед Ресёрч Компани Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сан Фарма Адвансед Ресёрч Компани Лимитед filed Critical Сан Фарма Адвансед Ресёрч Компани Лимитед
Publication of EA201792445A1 publication Critical patent/EA201792445A1/ru
Publication of EA032697B1 publication Critical patent/EA032697B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C07B43/06—Formation or introduction of functional groups containing nitrogen of amide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Настоящее изобретение относится к новым амидогетероарилароилгидразидэтинам в качестве ингибиторов тирозинкиназ, способу их получения и применению данных соединений для получения фармацевтических композиций для терапевтического лечения у людей нарушений, связанных с тирозинкиназами.
EA201792445A 2015-05-18 2016-05-18 Амидогетероарилароилгидразидэтины EA032697B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1953MU2015 2015-05-18
PCT/IN2016/050142 WO2016185490A1 (en) 2015-05-18 2016-05-18 Novel amidoheteroaryl aroyl hydrazide ethynes

Publications (2)

Publication Number Publication Date
EA201792445A1 true EA201792445A1 (ru) 2018-04-30
EA032697B1 EA032697B1 (ru) 2019-07-31

Family

ID=57319598

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201792445A EA032697B1 (ru) 2015-05-18 2016-05-18 Амидогетероарилароилгидразидэтины

Country Status (13)

Country Link
US (1) US10150733B2 (ru)
EP (1) EP3297991B1 (ru)
JP (1) JP6689887B2 (ru)
KR (1) KR20180011772A (ru)
CN (1) CN107709300A (ru)
AU (1) AU2016263311A1 (ru)
BR (1) BR112017024633A2 (ru)
CA (1) CA2985161A1 (ru)
EA (1) EA032697B1 (ru)
ES (1) ES2774501T3 (ru)
MX (1) MX2017014752A (ru)
WO (1) WO2016185490A1 (ru)
ZA (1) ZA201707664B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA037697B1 (ru) * 2016-06-02 2021-05-12 Сан Фарма Адвансед Ресёрч Компани Лимитед Лечение болезни паркинсона
MX2018014944A (es) 2016-06-02 2019-03-07 Sun Pharma Advanced Res Co Ltd Tratamiento para la enfermedad de parkinson.
CA3056356A1 (en) 2017-03-15 2018-09-20 Sun Pharma Advanced Research Company Limited Amorphous dispersion of cyclopropanecarboxylic acid (5-{5-[n'-(2- chloro-6-methylbenzoyl) hydrazinocarbonyl]-2-methyl-phenylethynyl}-pyridin-2-yl) amide
CA3102381A1 (en) 2018-06-15 2019-12-19 Handa Oncology, Llc Kinase inhibitor salts and compositions thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023933A4 (en) * 2006-05-08 2011-02-23 Ariad Pharma Inc HETEROARYL ACETYLENE COMPOUNDS
WO2012089106A1 (zh) * 2010-12-27 2012-07-05 Sun Shuping 作为蛋白激酶抑制剂的芳炔类衍生物及其医疗用途
KR101892574B1 (ko) * 2011-01-21 2018-08-28 썬 파마 어드밴스트 리서치 컴패니 리미티드 디아릴아세틸렌 히드라지드 함유 티로신 키나제 억제제
US8859541B2 (en) * 2012-02-27 2014-10-14 Boehringer Ingelheim International Gmbh 6-alkynylpyridines

Also Published As

Publication number Publication date
EP3297991A1 (en) 2018-03-28
US20180127372A1 (en) 2018-05-10
EP3297991A4 (en) 2018-11-21
MX2017014752A (es) 2018-03-23
ZA201707664B (en) 2019-08-28
EP3297991B1 (en) 2020-01-29
CA2985161A1 (en) 2016-11-24
BR112017024633A2 (pt) 2018-07-31
KR20180011772A (ko) 2018-02-02
JP2018515550A (ja) 2018-06-14
WO2016185490A1 (en) 2016-11-24
CN107709300A (zh) 2018-02-16
ES2774501T3 (es) 2020-07-21
JP6689887B2 (ja) 2020-04-28
EA032697B1 (ru) 2019-07-31
US10150733B2 (en) 2018-12-11
AU2016263311A1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
EA201792047A1 (ru) Новые соединения
EA201691134A1 (ru) Новые ингибиторы глутаминазы
EA201792619A1 (ru) Нафтиридиновые соединения в качестве ингибиторов jak киназы
MX2020012165A (es) Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cancer.
EA201791018A1 (ru) Производные 6-амино-7-бицикло-7-деазапурина в качестве ингибиторов протеинкиназы
EA201891910A1 (ru) Гетероарильные ингибиторы pad4
EA201790273A1 (ru) Флагеллиновые композиции и их применение
NZ729603A (en) Heteroaryl compounds as btk inhibitors and uses thereof
EA201591591A1 (ru) Соединения карбазола, применяемые в качестве ингибиторов бромодомена
JO3512B1 (ar) مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
EA201691872A1 (ru) Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201691114A1 (ru) Биарильные соединения, применяемые при лечении заболеваний человека в онкологии, нефрологии и иммунологии
EA201891251A1 (ru) Бициклические ингибиторы pad4
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
EA201792689A1 (ru) Производные 2-(пиразолопиридин-3-ил)пиримидина в качестве ингибиторов jak
EA201592113A1 (ru) Двойные селективные ингибиторы pi3-киназ дельта и гамма
EA201691481A1 (ru) ИНГИБИТОРЫ C5a ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ПНЕВМОНИИ
EA201891347A1 (ru) Аза-бензимидазольные ингибиторы pad4
EA201592238A1 (ru) Ингибиторы протеинкиназы pi3k, в частности ингибиторы pi3k дельта и/или гамма
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
EA201691032A1 (ru) Производные изохромена в качестве ингибиторов фосфоинозитид-3-киназ
EA201790745A1 (ru) Трициклические соединения
EA201692470A1 (ru) Фармацевтические комбинации
TW201613577A (en) Pharmaceutical combinations

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU